A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine
-
Published:2024-08-11
Issue:1
Volume:15
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Latzer PaulineORCID, Zelba Henning, Battke FlorianORCID, Reinhardt Annekathrin, Shao Borong, Bartsch Oliver, Rabsteyn Armin, Harter Johannes, Schulze Martin, Okech Thomas, Golf Alexander, Kyzirakos-Feger Christina, Kayser Simone, Pieper Natalia, Feldhahn Magdalena, Wünsche Julian, Seitz Christian, Hadaschik Dirk, Garbe Claus, Hauser Till-KarstenORCID, la Fougère ChristianORCID, Biskup Dirk, Brooke Dawn, Parker David, Martens Uwe M.ORCID, Illerhaus Gerald, Blumenthal Deborah T.ORCID, Merrell Ryan, Lorenzo Luisa Sánchez, Hidvégi MátéORCID, de Robles Paula, Kebir Sied, Li William W., Li Vincent W., Williams Matthew, Miller Alexandra M., Kesari SantoshORCID, Castro Michael, Desjardins AnnickORCID, Ashley David M.ORCID, Friedman Henry S.ORCID, Wen Patrick Y., Neil Elisabeth C., Iwamoto Fabio M., Sipos BenceORCID, Geletneky Karsten, Zender LarsORCID, Glas Martin, Reardon David A.ORCID, Biskup SaskiaORCID
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987–996 (2005). 2. Stupp, R. et al. NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur. J. Cancer 48, 2192–2202 (2012). 3. Stupp, R. et al. Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA 314, 2535–2543 (2015). 4. Stupp, R. et al. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA 318, 2306–2316 (2017). 5. Chinot, O. L. et al. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N. Engl. J. Med. 370, 709–722 (2014).
|
|